Recent studies have indicated an association between NOTCH1 or NOTCH3 and cisplatin resistance in squamous head and neck and ovarian carcinomas and in EBV-associated naso-pharynx carcinomas, respectively (17–19). This evidence concerns the gene NOTCH3 and ovarian carcinoma.